These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10138581)

  • 21. The impact of a pharmacist-managed dosage form conversion service on ciprofloxacin usage at a major Canadian teaching hospital: a pre- and post-intervention study.
    Ho BP; Lau TT; Balen RM; Naumann TL; Jewesson PJ
    BMC Health Serv Res; 2005 Jun; 5():48. PubMed ID: 15987523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conversion of intravenous ranitidine to oral therapy.
    Baciewicz AM
    DICP; 1991 Mar; 25(3):251-2. PubMed ID: 2028631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost of wastage in a hospital intravenous admixture program.
    Salberg DJ; Newton RW; Leduc DT
    Hosp Formul; 1984 May; 19(5):375-8. PubMed ID: 10266241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variable cost per dose of preparing and administering small-volume cephalosporin admixtures. Veterans Administration Pharmacy Service Study Group.
    Am J Hosp Pharm; 1984 Dec; 41(12):2624-34. PubMed ID: 6517086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic impact of a pharmacy resident in an assisted living facility-based medication therapy management program.
    Maack B; Miller DR; Johnson T; Dewey M
    Ann Pharmacother; 2008 Nov; 42(11):1613-20. PubMed ID: 18940921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A practical approach enabling staff pharmacists to prospectively review and dose aminoglycoside therapy.
    Possidente CJ; Lynch T
    Hosp Pharm; 1988 Nov; 23(11):976-8, 981-3. PubMed ID: 10290757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of clinical pharmacists to cefazolin utilization.
    Witte KW; Hatoum HT; Hoon TJ
    Hosp Formul; 1987 Aug; 22(8):737-41. PubMed ID: 10283405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Productivity and quality assessment associated with conversion from i.v. to oral ranitidine.
    Baciewicz AM; Cowan RI
    Hosp Formul; 1993 Apr; 28(4):397-8. PubMed ID: 10125324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A prospective comparative study to assess the impact of pharmaceutical intervention in the promotion of sequential therapy with flouroquinolones].
    Pinteño Blanco M; Delgado Sánchez O; Escrivá Torralva A; Crespí Monjo M; Ventayol Bosch P; Puigventós Latorre F; Martínez López I
    Farm Hosp; 2004; 28(6):419-25. PubMed ID: 15628944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug dosage adjustments according to renal function at hospital discharge.
    van Dijk EA; Drabbe NR; Kruijtbosch M; De Smet PA
    Ann Pharmacother; 2006; 40(7-8):1254-60. PubMed ID: 16804098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventing adverse events in the pediatric intensive care unit: prospectively targeting factors that lead to intravenous potassium chloride order errors.
    White JR; Veltri MA; Fackler JC
    Pediatr Crit Care Med; 2005 Jan; 6(1):25-32. PubMed ID: 15636655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of an antibiotic cost containment measure.
    Jung B; Andrews JD
    Can J Hosp Pharm; 1990 Jun; 43(3):116-22. PubMed ID: 10105649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost comparison of two systems for intermittent intravenous administration of small-volume injections.
    Reilly RT; Strand LM; Bair JN
    Am J Hosp Pharm; 1985 Feb; 42(2):323-8. PubMed ID: 3976678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of a target drug monitoring program on the usage of clindamycin.
    Gin AS; Lipinski LA; Honcharik N
    Can J Hosp Pharm; 1994 Apr; 47(2):53-8. PubMed ID: 10134127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medication dosing errors in hospitalized patients with renal impairment: a study in Palestine.
    Sweileh WM; Janem SA; Sawalha AF; Abu-Taha AS; Zyoud SH; Sabri IA; Al-Jabi SW; Jaradat NA; Zaid AA
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):908-12. PubMed ID: 17464934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Automation is prescription for revamping pharmacy services at North Carolina hospital.
    Health Care Cost Reengineering Rep; 1998 Apr; 3(4):53-6. PubMed ID: 10178978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center.
    Warren DK; Shukla SJ; Olsen MA; Kollef MH; Hollenbeak CS; Cox MJ; Cohen MM; Fraser VJ
    Crit Care Med; 2003 May; 31(5):1312-7. PubMed ID: 12771596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation of pharmaceutical care in acute medical cardiovascular patients.
    Chisholm MA; Pittman DG; Longley JM; Mullis SR
    Hosp Pharm; 1995 Jul; 30(7):572-4, 577-8. PubMed ID: 10144212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A practical approach to achieving a $950,000 cost savings from a joint anesthesia-pharmacy program.
    Durfee DD
    Hosp Pharm; 1995 Nov; 30(11):957-8, 961-3. PubMed ID: 10152916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategy for developing a safe and cost-effective H2-receptor antagonist program.
    Quercia RA; Chow MS; Jay GT; Quintiliani R
    Hosp Formul; 1991 Nov; 26 Suppl D():20-4. PubMed ID: 10136561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.